Dr. Laflamme is a founding investigator of BlueRock Therapeutics and is a senior scientist at Toronto General Hospital Research Institute. Dr. Laflamme is a leader in the field of cardiac physiology, stem cell-derived cardiac tissues, and cardiac pacemaker cells. Dr. Laflamme earned an M.D., Ph.D. degree in physiology and pharmacology from Emory University School of Medicine. He holds a Bachelor of Science degree in physics from Georgetown University.